HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Yuan Ren Selected Research

Radiotherapy

9/2011Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Yuan Ren Research Topics

Disease

1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2011
1Colonic Neoplasms (Colon Cancer)
08/2011
1Hepatocellular Carcinoma (Hepatoma)
05/2009
1Neoplasms (Cancer)
05/2009

Drug/Important Bio-Agent (IBA)

3(1,2- bis(1,2- benzisoselenazolone- 3(2H)- ketone))ethaneIBA
09/2011 - 05/2009
3Thioredoxin-Disulfide ReductaseIBA
09/2011 - 05/2009
1SeleniumIBA
09/2011
1Cisplatin (Platino)FDA LinkGeneric
08/2011
1AcidsIBA
05/2009
1Dithionitrobenzoic Acid (Ellman's Reagent)IBA
05/2009

Therapy/Procedure

1Radiotherapy
09/2011